Increased release of von Willebrand factor antigen from endothelial cells by anti-DNA autoantibodies.
Open Access
- 1 January 1996
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 55 (1) , 57-62
- https://doi.org/10.1136/ard.55.1.57
Abstract
OBJECTIVE--To determine whether antibodies to double stranded DNA (anti-dsDNA) have a pathogenic role in systemic lupus erythematosus (SLE). METHODS--IgG was purified from 17 patients with SLE (median anti-dsDNA titre 1212 IU/ml) and nine healthy controls (median titre 40 IU/ml). Anti-dsDNA depleted polyclonal IgG (median anti-dsDNA titre 17 IU/ml) was also prepared from sera of the 17 patients by affinity chromatography on a DNA cellulose column. Binding to antiendothelial cell antibodies (AECA) and expression of von Willebrand factor (VWF) antigen by cultured human umbilical vein endothelial cells (HUVECs) were studied by flow cytometry. RESULTS--The percentage of HUVECs binding to AECA or expressing VWF was greater for cells incubated with IgG from patients with SLE than for cells incubated with control IgG, though values did not reach statistical significance; nevertheless, HUVECs incubated with IgG from patients expressed a greater mean fluorescence intensity with AECA (p = 0.0001) and greater VWF expression (p = 0.019). Both the fluorescence intensity and percentage of HUVECs binding to AECA or expressing VWF were significantly greater in HUVEC incubated with IgG containing anti-dsDNA than in those incubated with anti-dsDNA depleted IgG. The concentration of VWF in the supernatant was significantly increased in HUVECs incubated with IgG containing anti-dsDNA compared with control IgG or anti-dsDNA depleted IgG. Pretreatment of HUVECs with native DNA before incubation with IgG from lupus patients did not increase binding to AECA, or expression or release of VWF. CONCLUSIONS--Our study provides in vitro evidence that antibodies to DNA have a pathogenic role in the induction of inflammatory injury of the vascular endothelium in SLE.Keywords
This publication has 29 references indexed in Scilit:
- Autoantibodies to Vascular Heparan Sulfate Proteoglycan in Systemic Lupus Erythematosus React with Endothelial Cells and Inhibit the Formation of Thrombin-Antithrombin III ComplexesClinical Immunology and Immunopathology, 1994
- The Origin, Sequence, Structure, and Consequences of Developing Anti‐DNA AntibodiesArthritis & Rheumatism, 1994
- Modulation of MHC Expression on Human Endothelial Cells by Sera from Patients with Systemic Lupus ErythematosusClinical Immunology and Immunopathology, 1993
- MARKERS OF ENDOTHELIAL PERTURBATION AND DAMAGERheumatology, 1993
- STIMULATION OF VON WILLEBRAND FACTOR ANTIGEN RELEASE BY IMMUNOGLOBULIN FROM THROMBOSIS PRONE PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND THE ANTIPHOSPHOLIPID SYNDROMERheumatology, 1993
- Identification of DNA-binding proteins on human umbilical vein endothelial cell plasma membraneClinical and Experimental Immunology, 1993
- Circulating DNA and lupus nephritisKidney International, 1988
- Cross-reactions of anti-DNA antibodies and the central dogma of lupus nephritisImmunology Today, 1985
- Suppression of NZB/NZW murine nephritis by administration of a syngeneic monoclonal antibody to DNA. Possible role of anti-idiotypic antibodies.Journal of Clinical Investigation, 1983
- Avidity of anti-DNA antibodies in serum and IgG glomerular eluates from patients with systemic lupus erythematosus. Association of high avidity antinative DNA antibody with glomerulonephritis.Journal of Clinical Investigation, 1977